/Bristol-Myers%20Squibb%20Co_%20logo%20on%20building-by%20tatu%20Campelo%20via%20iStock.jpg)
Bristol-Myers Squibb Company (BMY), headquartered in New York and with a market cap of $121.6 billion, is a global leader in biopharmaceutical innovation. Known for its expertise in developing life-saving therapies across oncology, immunology, cardiovascular, and hematology, Bristol-Myers Squibb plays a critical role in advancing healthcare, improving patient outcomes, and driving medical progress worldwide.
Companies worth $10 billion or more are described as “large-cap stocks,” Bristol-Myers Squibb fits this category. As a global biopharma leader, Bristol-Myers Squibb focuses on discovering, developing, and delivering innovative medicines that address serious diseases. With a robust portfolio of life-saving therapies and a presence in markets worldwide, the company has solidified its position as a key player in advancing healthcare and improving patient outcomes globally.